BPCR Biopharma Credit Plc

TIDMBPCR

RNS Number : 2831R

BioPharma Credit PLC

27 February 2019

27 February 2019

BIOPHARMA CREDIT PLC

(the "Company")

NOTICE OF FULL YEAR RESULTS

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Full Year Results for the period ending 31 December 2018, on Tuesday 5 March 2019.

A management presentation will be delivered at 2:00pm GMT through a conference call facility, to request conference call details, RSVP to henryw@buchanan.uk.com.

-Ends-

Enquiries

BioPharma Credit PLC

via Link Company Matters Limited

Company Secretary

+44 (0) 1392 477 500

Buchanan

+44 (0)20 7466 5000

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

biopharmacredit@buchanan.uk.com

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORPGUUPPUPBGUM

(END) Dow Jones Newswires

February 27, 2019 05:40 ET (10:40 GMT)

Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Mar 2024 to May 2024

Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024